Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (49)

2024

  1. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

  2. Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 55-58

2023

  1. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

    Biomedicines, Vol. 11, Núm. 2

  2. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study

    Journal of Clinical Medicine, Vol. 12, Núm. 13

2022

  1. Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies

    Journal of Translational Autoimmunity, Vol. 5

2021

  1. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  2. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28

2020

  1. Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 3, pp. e15699

  2. Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 3, pp. e15699

  3. Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients: EFIMERA observational study

    npj Primary Care Respiratory Medicine, Vol. 30, Núm. 1

2019

  1. Treatment of exacerbations of COPD

    Revista de Patologia Respiratoria, Vol. 22, pp. S195-S201

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Evaluating the impact of morning symptoms in COPD using the capacity of daily living during the morning (CDLM) questionnaire

    International Journal of COPD, Vol. 13, pp. 3837-3844

  3. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study

    Archivos de Bronconeumologia, Vol. 54, Núm. 5, pp. 270-279

2017

  1. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

    Respiratory Research, Vol. 18, Núm. 1

  2. Clinical audit of COPD in outpatient respiratory clinics in Spain: The EPOCONSUL study

    International Journal of COPD, Vol. 12, pp. 417-426

  3. Fortalezas y aportaciones de la Guía española de la EPOC (GesEPOC) 2017

    Revista de Patologia Respiratoria

2016

  1. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52

  2. Determinants of use of the bronchodilator test in primary and secondary care: Results of a national survey in Spain

    Clinical Respiratory Journal, Vol. 10, Núm. 2, pp. 217-222

  3. Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort

    PLoS ONE, Vol. 11, Núm. 9